@article{asselah:hal-03590861, TITLE = {{Efficacy and Safety of Elbasvir/Grazoprevir for 8 or 12 Weeks in Participants with Hepatitis C Virus Genotype 4 Infection}}, AUTHOR = {Asselah, Tarik and Pol, Stanislas and Hezode, Christophe and Ratti, Veronique Loustaud and Leroy, Vincent and Ahmed, Si Nafa Si and Ozenne, Violaine and Bronowicki, Jean-Pierre and Larrey, Dominique and Tran, Albert and Alric, Laurent and Nguyen-Khac, Eric and Robertson, Michael Newton and Hanna, George and Brown, Deborah and Asante-Appiah, Ernest and Ludmerer, Steve and Su, Feng-Hsiu and Hwang, Peggy and Klopfer, Stephanie and Hall, Jessie Durrand and Guidoum, Amir and Hagen, Karin and Haber, Barbara and Talwani, Rohit and Serfaty, Lawrence}, URL = {https://u-picardie.hal.science/hal-03590861}, NOTE = {Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD) / Liver Meeting, San Francisco, CA, NOV 09-13, 2018}, JOURNAL = {{Hepatology}}, PUBLISHER = {{Wiley-Blackwell}}, VOLUME = {68}, NUMBER = {1}, PAGES = {385A}, YEAR = {2018}, HAL_ID = {hal-03590861}, HAL_VERSION = {v1}, }